rheumatoid arthritis Scipher Medicine Buys Software Firm CrossBridge Precision immunology firm Scipher said the acquisition of Philadelphia-based CrossBridge is intended to strengthen its data management and analytics capabilities. Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment Histological profiling and RNA sequencing helped identify synovial biopsy features for predicting targeted biologic therapy response in rheumatoid arthritis. Myriad Genetics Settles Anti-Kickback Lawsuit Related to Vectra DA Myriad will pay $45.25 million to the federal and California state governments and $2.75 million to the whistleblower in exchange for dismissal of the case and all claims against it. Scipher Medicine Solidifies Path Forward With New Financing and Data on PrismRA Test Premium The company is hoping to gain a local coverage determination from CMS this year as it solidifies data for its first assay and works on building out a larger menu. Scipher Medicine Nabs $110M in Financing The company is advancing a pipeline of RNA-based immune disease assays, spearheaded by its PrismRA test to guide therapy for rheumatoid arthritis. Jan 10, 2022 Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection Mar 24, 2021 Scipher Medicine Raises $82M in Series C Financing Jan 5, 2021 Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence Sep 17, 2020 Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test Aug 5, 2020 Scipher Medicine to Launch PrismRA Anti-TNF Response Predictor Following Positive Data Publication Premium Jul 16, 2020 Rheumatoid Arthritis Flare-Up Clues Found in Blood Transcriptomes Tested Over Time Jun 9, 2020 Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed Premium Apr 17, 2020 Svar Life Science, Nimble Therapeutics Form Diagnostics Alliance Feb 19, 2020 Scipher Medicine Raises Series B Financing Total to $25M Dec 19, 2019 Scipher Medicine Closes Series B Funding Round Apr 9, 2019 Somalogic Collaborating With Janssen on Protein Biomarker Research Jan 9, 2019 Scipher Medicine Builds Evidence for Tests Predicting Response to Autoimmune Disease Drugs Premium Sep 18, 2018 Type 1 Diabetes, Rheumatoid Arthritis Causal Variants Defined by Fine Mapping, Functional Analyses Sep 4, 2018 Identical Twins With, Without Rheumatoid Arthritis Have Differentially Variable DNA Methylation Jul 18, 2018 Kroger Prescription Plans to Offer Myriad Genetics' Vectra DA as Benefit Option May 8, 2018 Myriad's Fiscal Q3 Revenues Fall 2 Percent but Beat Wall Street Expectations May 7, 2018 HTG Molecular, Firalis Ink Deal for RA Theranostic Technology Apr 11, 2018 Pfizer, Oxford BioDynamics, U of Glasgow Researchers Develop Approach to Gauge Response to RA Drug Premium Dec 7, 2017 BGI, Sanguine BioSciences Developing Patient Database for Trial Recruitment Jan 20, 2017 Immunovia's Blood-Based Array Test for Lupus Advances in New Study Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.